成人1型糖尿病识别与研究的挑战
本文讨论成人1型糖尿病诊断困难与误分类问题,指出按高特异性方法定义时,临床表现、胰岛自身抗体阳性、遗传易感性和C肽丢失进展在各年龄成人中相似且严重;近期临床指南推荐在临床怀疑1型糖尿病或2型糖尿病诊断后快速进展至胰岛素治疗时常规检测胰岛自身抗体,但反对对明显2型糖尿病患者常规检测。
要点
- 成人1型糖尿病诊断困难,因2型糖尿病占主导,尤其发病年龄约>30岁者,误分类常见。
- 按高特异性方法定义1型糖尿病时,临床表现、胰岛自身抗体阳性、遗传易感性和C肽丢失进展在各年龄成人中相似且严重。
- 近期临床指南推荐临床怀疑1型糖尿病或2型糖尿病诊断后快速进展至胰岛素治疗时常规检测胰岛自身抗体。
核心结论
- 成人1型糖尿病误分类常见,影响患者管理和临床分类队列的特征报告。
- 按高特异性方法定义时,成人1型糖尿病的临床表现、胰岛自身抗体阳性、遗传易感性和C肽丢失进展在各年龄中相似且严重。
- 在中等或高先验概率下,胰岛自身抗体阳性通常可确认自身免疫病因(1型糖尿病)。
研究设计与样本
- 本文为综述,讨论成人1型糖尿病识别与研究的挑战。
主要发现
- 许多报告的自身免疫/1型糖尿病特征随诊断年龄增加而不同的差异,可能由无意中研究混合人群(有或无自身免疫病因糖尿病)解释。
- 按高特异性方法定义1型糖尿病时,临床表现、胰岛自身抗体阳性、遗传易感性和C肽丢失进展在各年龄成人中保持 broadly similar 且严重,不受成人内发病年龄影响。
- 对明显2型糖尿病患者常规检测胰岛自身抗体不应进行,因在低先验 prevalence 设置下,单阳性胰岛抗体对自身免疫病因糖尿病的阳性预测值仅为 modest。
关键数值与推荐
- 近期临床指南推荐:临床怀疑1型糖尿病或2型糖尿病诊断后快速进展至胰岛素治疗时,常规检测胰岛自身抗体。
- 在中等或高先验概率设置下,胰岛自身抗体阳性通常确认自身免疫病因(1型糖尿病)。
临床怎么用
- 临床怀疑1型糖尿病或2型糖尿病诊断后快速进展至胰岛素治疗时,推荐常规检测胰岛自身抗体。
- 对明显2型糖尿病患者不应常规进行胰岛自身抗体检测。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diagnosing type 1 diabetes in adults is difficult since type 2 diabetes is the predominant diabetes type, particularly with an older age of onset (approximately >30 years). Misclassification of type 1 diabetes in adults is therefore common and will impact both individual patient management and the reported features of clinically classified cohorts. In this article, we discuss the challenges associated with correctly identifying adult-onset type 1 diabetes and the implications of these challenges for clinical practice and research. We discuss how many of the reported differences in the characteristics of autoimmune/type 1 diabetes with increasing age of diagnosis are likely explained by the inadvertent study of mixed populations with and without autoimmune aetiology diabetes. We show that when type 1 diabetes is defined by high-specificity methods, clinical presentation, islet-autoantibody positivity, genetic predisposition and progression of C-peptide loss remain broadly similar and severe at all ages and are unaffected by onset age within adults. Recent clinical guidance recommends routine islet-autoantibody testing when type 1 diabetes is clinically suspected or in the context of rapid progression to insulin therapy after a diagnosis of type 2 diabetes. In this moderate or high prior-probability setting, a positive islet-autoantibody test will usually confirm autoimmune aetiology (type 1 diabetes). We argue that islet-autoantibody testing of those with apparent type 2 diabetes should not be routinely undertaken as, in this low prior-prevalence setting, the positive predictive value of a single-positive islet antibody for autoimmune aetiology diabetes will be modest. When studying diabetes, extremely high-specificity approaches are needed to identify autoimmune diabetes in adults, with the optimal approach depending on the research question. We believe that until these recommendations are widely adopted by researchers, the true phenotype of late-onset type 1 diabetes will remain largely misunderstood.
引用
- Thomas NJ, Jones AG. The challenges of identifying and studying type 1 diabetes in adults. Diabetologia. 2023. PMID: 37728732. doi:10.1007/s00125-023-06004-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。